NasdaqCM - Delayed Quote USD
Spruce Biosciences, Inc. (SPRB)
0.0600
-0.0049
(-7.55%)
As of 10:37:56 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 2 |
| Avg. Estimate | -0.15 | -0.15 | -0.58 | -1.2 |
| Low Estimate | -0.15 | -0.15 | -0.58 | -1.48 |
| High Estimate | -0.15 | -0.15 | -0.58 | -0.91 |
| Year Ago EPS | -0.22 | -0.21 | -1.29 | -0.58 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | 166.67k |
| Low Estimate | -- | -- | -- | -4.5M |
| High Estimate | -- | -- | -- | 5M |
| Year Ago Sales | 1.61M | 602k | 4.91M | -- |
| Sales Growth (year/est) | -100.00% | -100.00% | -100.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.32 | -0.23 | -0.2 | -0.26 |
| EPS Actual | -0.22 | -0.21 | -0.57 | -0.32 |
| Difference | 0.1 | 0.02 | -0.37 | -0.06 |
| Surprise % | 30.53% | 10.64% | -178.05% | -23.08% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.15 | -0.15 | -0.58 | -1.2 |
| 7 Days Ago | -0.25 | -0.24 | -0.85 | -1.23 |
| 30 Days Ago | -0.19 | -0.19 | -0.64 | -0.82 |
| 60 Days Ago | -0.19 | -0.19 | -0.64 | -0.82 |
| 90 Days Ago | -0.19 | -0.19 | -0.64 | -0.82 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | 1 | 1 | 2 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SPRB | 31.82% | 28.57% | 55.04% | -106.03% |
| S&P 500 | 13.32% | 2.61% | 7.73% | 13.77% |
Upgrades & Downgrades
| Maintains | RBC Capital: Sector Perform to Sector Perform | 4/16/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 12/16/2024 |
| Reiterates | Guggenheim: Neutral to Neutral | 12/12/2024 |
| Downgrade | JMP Securities: Market Outperform to Market Perform | 12/11/2024 |
| Reiterates | RBC Capital: Sector Perform to Sector Perform | 12/11/2024 |
| Downgrade | Oppenheimer: Outperform to Perform | 12/11/2024 |
Related Tickers
BOLT Bolt Biotherapeutics, Inc.
0.3202
-2.88%
KZR Kezar Life Sciences, Inc.
4.1200
+0.24%
ANTX AN2 Therapeutics, Inc.
1.1900
0.00%
IKNA Ikena Oncology, Inc.
1.1440
+1.24%
HLVX HilleVax, Inc.
1.9300
-4.46%
ATHA Athira Pharma, Inc.
0.2692
+0.41%
GRTX Galera Therapeutics, Inc.
0.0240
0.00%
CRGX CARGO Therapeutics, Inc.
4.1250
+0.61%
EPIX ESSA Pharma Inc.
1.6650
+0.91%
TTI.V Thiogenesis Therapeutics, Corp.
0.7200
-1.37%